Last reviewed · How we verify
Autologous Muscle Progenitor Cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Autologous Muscle Progenitor Cells (Autologous Muscle Progenitor Cells) — Wake Forest University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Autologous Muscle Progenitor Cells TARGET | Autologous Muscle Progenitor Cells | Wake Forest University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Autologous Muscle Progenitor Cells CI watch — RSS
- Autologous Muscle Progenitor Cells CI watch — Atom
- Autologous Muscle Progenitor Cells CI watch — JSON
- Autologous Muscle Progenitor Cells alone — RSS
Cite this brief
Drug Landscape (2026). Autologous Muscle Progenitor Cells — Competitive Intelligence Brief. https://druglandscape.com/ci/autologous-muscle-progenitor-cells. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab